Blair McNamara, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, & Alessandro D. Santin. (2023). Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy. Elsevier.
Chicago Style (17th ed.) CitationBlair McNamara, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, and Alessandro D. Santin. Pembrolizumab and Lenvatinib in Recurrent Ovarian Clear Cell Carcinoma Resistant to Chemotherapy. Elsevier, 2023.
MLA (9th ed.) CitationBlair McNamara, et al. Pembrolizumab and Lenvatinib in Recurrent Ovarian Clear Cell Carcinoma Resistant to Chemotherapy. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.